Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-29 Purchase |
2023-10-03 4:00 pm |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
24,670 | $13.63 | $336,252 | 1,928,503 (Indirect) |
View |
| 2023-09-26 Purchase |
2023-09-28 5:09 pm |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
30,000 | $13.15 | $394,500 | 1,903,833 (Indirect) |
View |
| 2023-09-21 Purchase |
2023-09-25 4:15 pm |
Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat Chief Medical Officer |
4,000 | $13.2 | $52,800 | 4,000 (Direct) |
View |
| 2023-09-19 Purchase |
2023-09-21 4:23 pm |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
30,000 | $13.2 | $396,000 | 1,873,833 (Indirect) |
View |
| 2023-09-12 Purchase |
2023-09-13 9:17 pm |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
24,254 | $11.2 | $271,680 | 1,850,333 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-04 Option Award |
2025-03-05 5:02 pm |
N/A 2035-03-04 |
Dianthus Therapeutics Inc. | DNTH | KANGO SUJAY Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:27 pm |
N/A 2035-02-02 |
Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER |
60,000 | $0 | 60,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:23 pm |
N/A 2035-02-02 |
Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. |
100,000 | $0 | 100,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:21 pm |
N/A 2035-02-02 |
Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat CHIEF MEDICAL OFFICER |
150,000 | $0 | 150,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:18 pm |
N/A 2035-02-02 |
Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO |
150,000 | $0 | 150,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:13 pm |
N/A 2035-02-02 |
Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT |
340,000 | $0 | 340,000 (Direct) |
View |
| 2024-09-27 Other |
2024-10-01 8:00 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director |
62,146 | $0 | 2,762,837 (Indirect) |
View |
| 2024-09-16 Option Award |
2024-09-18 5:38 pm |
N/A 2034-09-15 |
Dianthus Therapeutics Inc. | DNTH | Romano Steven J. Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 8:05 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 8:05 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. |
75,000 | $0 | 75,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 8:04 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat CHIEF MEDICAL OFFICER |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 8:04 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 8:03 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT |
243,000 | $0 | 243,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 8:02 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | Violin Jonathan Director |
11,000 | $0 | 11,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 7:59 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director |
11,000 | $0 | 11,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 7:58 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | MOULDER LEON O JR Director |
11,000 | $0 | 11,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 7:58 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | McGeorge Anne Director |
11,000 | $0 | 11,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 7:58 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | Lawton Alison Frances Director |
11,000 | $0 | 11,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 7:57 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director |
11,000 | $0 | 11,000 (Indirect) |
View |
| 2024-04-01 Other |
2024-04-01 6:21 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director |
58,857 | $0 | 2,880,551 (Indirect) |
View |
| 2024-01-24 Option Award |
2024-01-26 4:51 pm |
N/A 2034-01-23 |
Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER |
80,000 | $0 | 80,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 4:46 pm |
N/A 2034-01-23 |
Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. |
110,000 | $0 | 110,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 4:43 pm |
N/A 2034-01-23 |
Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat CHIEF MEDICAL OFFICER |
120,000 | $0 | 120,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 4:41 pm |
N/A 2034-01-23 |
Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CHIEF FINANCIAL OFFICER |
120,000 | $0 | 120,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 4:36 pm |
N/A 2034-01-23 |
Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT |
275,000 | $0 | 275,000 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-24 7:04 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | MOULDER LEON O JR Director |
166,667 | $12 | 1,436,745 (Indirect) |
View |
| 2024-01-22 Option Award |
2024-01-24 7:02 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
832,333 | $12 | 3,595,170 (Indirect) |
View |
| 2024-01-22 Option Award |
2024-01-24 7:02 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
834,334 | $12 | 3,595,170 (Indirect) |
View |
| 2024-01-22 Option Award |
2024-01-24 6:55 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Meng Lei Avidity Partners Management LP Gregory Michael David Avidity Partners Management (GP) LLC Witzke David Roy Director |
1,833,333 | $12 | 4,550,887 (Indirect) |
View |
| 2024-01-22 Option Award |
2024-01-24 6:55 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Meng Lei Avidity Partners Management LP Gregory Michael David Avidity Partners Management (GP) LLC Witzke David Roy Director |
1,500,000 | $12 | 4,550,887 (Indirect) |
View |
| 2023-09-11 Option Award |
2023-09-13 9:56 pm |
N/A 2033-09-10 |
Dianthus Therapeutics Inc. | DNTH | Meng Lei Avidity Partners Management LP Director |
6,500 | $0 | 6,500 (Indirect) |
View |
Ownership |
2023-09-13 9:31 pm |
N/A N/A |
Dianthus Therapeutics Inc. | DNTH | Meng Lei Avidity Partners Management LP Director |
0 | $0 | 1,217,554 (Indirect) |
View |
| 2023-09-11 Option Award |
2023-09-13 9:25 pm |
N/A 2033-09-10 |
Dianthus Therapeutics Inc. | DNTH | Violin Jonathan Director |
6,500 | $0 | 6,500 (Direct) |
View |
| 2023-09-11 Option Award |
2023-09-13 9:17 pm |
N/A 2033-09-10 |
Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner |
6,500 | $0 | 1,850,333 (Indirect) |
View |
| 2023-09-11 Option Award |
2023-09-13 9:17 pm |
N/A 2033-09-10 |
Dianthus Therapeutics Inc. | DNTH | Lawton Alison Frances Director |
6,500 | $0 | 6,500 (Direct) |
View |
| 2023-09-11 Option Award |
2023-09-13 9:16 pm |
N/A 2033-09-10 |
Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director |
6,500 | $0 | 6,500 (Direct) |
View |